Accessory proteins for heterotrimeric G-protein: Implication in the cardiovascular system

Pathophysiology

Volumn 17, Issue 2, 2010, Pages 89-99

  Sato, Motohiko ^a   Ishikawa, Yoshihiro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Activator of G protein signaling (AGS); Cardiovascular disease; Heterotrimeric G protein; Regulator of G protein signaling (RGS); Signal transduction

Indexed keywords

ACTIVATOR OF G PROTEIN SIGNALING 1 PROTEIN; ACTIVATOR OF G PROTEIN SIGNALING 3 PROTEIN; DEXAMETHASONE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NEUROMODULIN; PHOSDUCIN; PHOSDUCIN LIKE PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PRESENILIN 1; RAS PROTEIN; RECEPTOR FOR ACTIVATED C KINASE 1; RGS2 PROTEIN; RGS4 PROTEIN; SYNTAXIN 1A; TUBULIN; UNCLASSIFIED DRUG;

ALPHA CHAIN; BETA CHAIN; BINDING SITE; BLOOD PRESSURE REGULATION; CARBOXY TERMINAL SEQUENCE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; HEART FAILURE; HEART FUNCTION; HEART INNERVATION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE HYPERTROPHY; HUMAN; METABOLIC REGULATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN STABILITY; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 77649189888     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.03.011     Document Type: Review

References (118)

1. Salazar N.C., Chen J., and Rockman H.A. Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim. Biophys. Acta 1768 (2007) 1006-1018
2. Liu G.S., Thornton J., Van Winkle D.M., Stanley A.W., Olsson R.A., and Downey J.M. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84 (1991) 350-356
3. Kitakaze M., Hori M., Takashima S., Sato H., Inoue M., and Kamada T. Ischemic preconditioning increases adenosine release and 5′-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage. Circulation 87 (1993) 208-215
4. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., Rosenfeldt H.M., Nava V.E., Chae S.S., Lee M.J., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106 (2000) 951-961
5. Ishikawa Y., and Homcy C.J. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ. Res. 80 (1997) 297-304
6. Birnbaumer L. Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimers. Biochim. Biophys. Acta 1768 (2007) 772-793
7. Smrcka A.V. G protein betagamma subunits: central mediators of G protein-coupled receptor signaling. Cell. Mol. Life Sci. 65 (2008) 2191-2214
8. Sato M., Kataoka R., Dingus J., Wilcox M., Hildebrandt J.D., and Lanier S.M. Factors determining specificity of signal transduction by G-protein-coupled receptors. Regulation of signal transfer from receptor to G-protein. J. Biol. Chem. 270 (1995) 15269-15276
9. Sato M., Ribas C., Hildebrandt J.D., and Lanier S.M. Characterization of a G-protein activator in the neuroblastoma-glioma cell hybrid NG108-15. J. Biol. Chem. 271 (1996) 30052-30060
10. Marjamaki A., Sato M., Bouet-Alard R., Yang Q., Limon-Boulez I., Legrand C., and Lanier S.M. Factors determining the specificity of signal transduction by guanine nucleotide-binding protein-coupled receptors. Integration of stimulatory and inhibitory input to the effector adenylyl cyclase. J. Biol. Chem. 272 (1997) 16466-16473
11. Zhang J., Sato M., Duzic E., Kubalak S.W., Lanier S.M., and Webb J.G. Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells. Am. J. Physiol. 273 (1997) H971-980
12. Ribas C., Takesono A., Sato M., Hildebrandt J.D., and Lanier S.M. Pertussis toxin-insensitive activation of the heterotrimeric G-proteins Gi/Go by the NG108-15 G-protein activator. J. Biol. Chem. 277 (2002) 50223-50225
13. Sato M., Gettys T.W., and Lanier S.M. AGS3 and signal integration by Galpha(s)- and Galpha(i)-coupled receptors: AGS3 blocks the sensitization of adenylyl cyclase following prolonged stimulation of a Galpha(i)-coupled receptor by influencing processing of Galpha(i). J. Biol. Chem. 279 (2004) 13375-13382
14. Sato M., Cismowski M.J., Toyota E., Smrcka A.V., Lucchesi P.A., Chilian W.M., and Lanier S.M. Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 797-802
15. Strittmatter S.M., Valenzuela D., Kennedy T.E., Neer E.J., and Fishman M.C. G0 is a major growth cone protein subject to regulation by GAP-43. Nature 344 (1990) 836-841
16. Strittmatter S.M., Valenzuela D., Sudo Y., Linder M.E., and Fishman M.C. An intracellular guanine nucleotide release protein for G0. GAP-43 stimulates isolated alpha subunits by a novel mechanism. J. Biol. Chem. 266 (1991) 22465-22471
17. Nishimoto I., Okamoto T., Matsuura Y., Takahashi S., Murayama Y., and Ogata E. Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o). Nature 362 (1993) 75-79
18. Smine A., Xu X., Nishiyama K., Katada T., Gambetti P., Yadav S.P., Wu X., Shi Y.C., Yasuhara S., Homburger V., et al. Regulation of brain G-protein go by Alzheimer's disease gene presenilin-1. J. Biol. Chem. 273 (1998) 16281-16288
19. Cismowski M.J., Takesono A., Ma C., Lizano J.S., Xie X., Fuernkranz H., Lanier S.M., and Duzic E. Genetic screens in yeast to identify mammalian nonreceptor modulators of G-protein signaling. Nat. Biotechnol. 17 (1999) 878-883
20. Takesono A., Cismowski M.J., Ribas C., Bernard M., Chung P., Hazard III S., Duzic E., and Lanier S.M. Receptor-independent activators of heterotrimeric G-protein signaling pathways. J. Biol. Chem. 274 (1999) 33202-33205
21. Kemppainen R.J., and Behrend E.N. Dexamethasone rapidly induces a novel ras superfamily member-related gene in AtT-20 cells. J. Biol. Chem. 273 (1998) 3129-3131
22. Cismowski M.J., Ma C., Ribas C., Xie X., Spruyt M., Lizano J.S., Lanier S.M., and Duzic E. Activation of heterotrimeric G-protein signaling by a ras-related protein. Implications for signal integration. J. Biol. Chem. 275 (2000) 23421-23424
23. Graham T.E., Key T.A., Kilpatrick K., and Dorin R.I. Dexras1/AGS-1, a steroid hormone-induced guanosine triphosphate-binding protein, inhibits 3′,5′-cyclic adenosine monophosphate-stimulated secretion in AtT-20 corticotroph cells. Endocrinology 142 (2001) 2631-2640
24. Yeung K., Seitz T., Li S., Janosch P., McFerran B., Kaiser C., Fee F., Katsanakis K.D., Rose D.W., Mischak H., et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401 (1999) 173-177
25. Yeung K., Janosch P., McFerran B., Rose D.W., Mischak H., Sedivy J.M., and Kolch W. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol. Cell. Biol. 20 (2000) 3079-3085
26. Lorenz K., Lohse M.J., and Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426 (2003) 574-579
27. Grandy D.K., Hanneman E., Bunzow J., Shih M., Machida C.A., Bidlack J.M., and Civelli O. Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Mol. Endocrinol. 4 (1990) 1370-1376
28. Kroslak T., Koch T., Kahl E., and Hollt V. Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling. J. Biol. Chem. 276 (2001) 39772-39778
29. Tall G.G., Krumins A.M., and Gilman A.G. Mammalian Ric-8A (synembryn) is a heterotrimeric Galpha protein guanine nucleotide exchange factor. J. Biol. Chem. 278 (2003) 8356-8362
30. Hildebrandt J.D. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem. Pharmacol. 54 (1997) 325-339
31. Downes G.B., and Gautam N. The G protein subunit gene families. Genomics 62 (1999) 544-552
32. Cismowski M.J. Non-receptor activators of heterotrimeric G-protein signaling (AGS proteins). Semin. Cell Dev. Biol. 17 (2006) 334-344
33. Blumer J.B., Smrcka A.V., and Lanier S.M. Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling. Pharmacol. Ther. 113 (2007) 488-506
34. Graham T.E., Qiao Z., and Dorin R.I. Dexras1 inhibits adenylyl cyclase. Biochem. Biophys. Res. Commun. 316 (2004) 307-312
35. Nguyen C.H., and Watts V.J. Dexras1 blocks receptor-mediated heterologous sensitization of adenylyl cyclase 1. Biochem. Biophys. Res. Commun. 332 (2005) 913-920
36. Vaidyanathan G., Cismowski M.J., Wang G., Vincent T.S., Brown K.D., and Lanier S.M. The Ras-related protein AGS1/RASD1 suppresses cell growth. Oncogene 23 (2004) 5858-5863
37. S.M. Lanier, A.P. Struckhoff, M.J. Cismowski, Ags1, UCSD-Nature Molecule Pages, 2007. doi:10.1038/mp.a000226.000201.
38. K.M. Yen, Mammalian blood loss-induced gene, kd312, US Patent #6,462,177 (1998).
39. Cheng H.Y., Obrietan K., Cain S.W., Lee B.Y., Agostino P.V., Joza N.A., Harrington M.E., Ralph M.R., and Penninger J.M. Dexras1 potentiates photic and suppresses nonphotic responses of the circadian clock. Neuron 43 (2004) 715-728
40. Strittmatter S.M., Cannon S.C., Ross E.M., Higashijima T., and Fishman M.C. GAP-43 augments G protein-coupled receptor transduction in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5327-5331
41. Zhou S., Chen L.S., Miyauchi Y., Miyauchi M., Kar S., Kangavari S., Fishbein M.C., Sharifi B., and Chen P.S. Mechanisms of cardiac nerve sprouting after myocardial infarction in dogs. Circ. Res. 95 (2004) 76-83
42. Miyauchi Y., Zhou S., Okuyama Y., Miyauchi M., Hayashi H., Hamabe A., Fishbein M.C., Mandel W.J., Chen L.S., Chen P.S., et al. Altered atrial electrical restitution and heterogeneous sympathetic hyperinnervation in hearts with chronic left ventricular myocardial infarction: implications for atrial fibrillation. Circulation 108 (2003) 360-366
43. Kimura K., Ieda M., Kanazawa H., Yagi T., Tsunoda M., Ninomiya S., Kurosawa H., Yoshimi K., Mochizuki H., Yamazaki K., et al. Cardiac sympathetic rejuvenation: a link between nerve function and cardiac hypertrophy. Circ. Res. 100 (2007) 1755-1764
44. Selkoe D.J., and Wolfe M.S. Presenilin: running with scissors in the membrane. Cell 131 (2007) 215-221
45. Nakajima M., Moriizumi E., Koseki H., and Shirasawa T. Presenilin 1 is essential for cardiac morphogenesis. Dev. Dyn. 230 (2004) 795-799
46. Li D., Parks S.B., Kushner J.D., Nauman D., Burgess D., Ludwigsen S., Partain J., Nixon R.R., Allen C.N., Irwin R.P., Jakobs P.M., Litt M., and Hershberger R.E. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am. J. Hum. Genet. 79 (2006) 1030-1039
47. Roychowdhury S., and Rasenick M.M. Tubulin-G protein association stabilizes GTP binding and activates GTPase: cytoskeletal participation in neuronal signal transduction. Biochemistry 33 (1994) 9800-9805
48. Roychowdhury S., Wang N., and Rasenick M.M. G protein binding and G protein activation by nucleotide transfer involve distinct domains on tubulin: regulation of signal transduction by cytoskeletal elements. Biochemistry 32 (1993) 4955-4961
49. Rasenick M.M., Donati R.J., Popova J.S., and Yu J.Z. Tubulin as a regulator of G-protein signaling. Methods Enzymol. 390 (2004) 389-403
50. Wang N., Yan K., and Rasenick M.M. Tubulin binds specifically to the signal-transducing proteins, Gs alpha and Gi alpha 1. J. Biol. Chem. 265 (1990) 1239-1242
51. Rasenick M.M., and Wang N. Exchange of guanine nucleotides between tubulin and GTP-binding proteins that regulate adenylate cyclase: cytoskeletal modification of neuronal signal transduction. J. Neurochem. 51 (1988) 300-311
52. Roychowdhury S., and Rasenick M.M. G protein beta1gamma2 subunits promote microtubule assembly. J. Biol. Chem. 272 (1997) 31576-31581
53. Sato M., Blumer J.B., Simon V., and Lanier S.M. Accessory proteins for G proteins: partners in signaling. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 151-187
54. Couwenbergs C., Spilker A.C., and Gotta M. Control of embryonic spindle positioning and Galpha activity by C. elegans RIC-8. Curr. Biol. 14 (2004) 1871-1876
55. Pizzinat N., Takesono A., and Lanier S.M. Identification of a truncated form of the G-protein regulator AGS3 in heart that lacks the tetratricopeptide repeat domains. J. Biol. Chem. 276 (2001) 16601-16610
56. Avidor-Reiss T., Bayewitch M., Levy R., Matus-Leibovitch N., Nevo I., and Vogel Z. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment. J. Biol. Chem. 270 (1995) 29732-29738
57. Watts V.J., and Neve K.A. Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol. Ther. 106 (2005) 405-421
58. Bowers M.S., McFarland K., Lake R.W., Peterson Y.K., Lapish C.C., Gregory M.L., Lanier S.M., and Kalivas P.W. Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron 42 (2004) 269-281
59. Yao L., McFarland K., Fan P., Jiang Z., Inoue Y., and Diamond I. Activator of G protein signaling 3 regulates opiate activation of protein kinase A signaling and relapse of heroin-seeking behavior. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 8746-8751
60. Blumer J.B., Lord K., Saunders T.L., Pacchioni A., Black C., Lazartigues E., Varner K.J., Gettys T.W., and Lanier S.M. Activator of G protein signaling 3 null mice. I. Unexpected alterations in metabolic and cardiovascular function. Endocrinology 149 (2008) 3842-3849
61. Berman D.M., Wilkie T.M., and Gilman A.G. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86 (1996) 445-452
62. Watson N., Linder M.E., Druey K.M., Kehrl J.H., and Blumer K.J. RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. Nature 383 (1996) 172-175
63. Riddle E.L., Schwartzman R.A., Bond M., and Insel P.A. Multi-tasking RGS proteins in the heart: the next therapeutic target?. Circ. Res. 96 (2005) 401-411
64. Hendriks-Balk M.C., Peters S.L., Michel M.C., and Alewijnse A.E. Regulation of G protein-coupled receptor signalling: focus on the cardiovascular system and regulator of G protein signalling proteins. Eur. J. Pharmacol. 585 (2008) 278-291
65. Zheng B., Ma Y.C., Ostrom R.S., Lavoie C., Gill G.N., Insel P.A., Huang X.Y., and Farquhar M.G. RGS-PX1, a GAP for GalphaS and sorting nexin in vesicular trafficking. Science 294 (2001) 1939-1942
66. Mittmann C., Chung C.H., Hoppner G., Michalek C., Nose M., Schuler C., Schuh A., Eschenhagen T., Weil J., Pieske B., et al. Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. Cardiovasc. Res. 55 (2002) 778-786
67. Owen V.J., Burton P.B., Mullen A.J., Birks E.J., Barton P., and Yacoub M.H. Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. Eur. Heart J. 22 (2001) 1015-1020
68. 2+ cycling proteins and G alpha q signaling after left ventricular assist device support in failing human hearts. Cardiovasc. Res. 45 (2000) 883-888
69. Heximer S.P., Knutsen R.H., Sun X., Kaltenbronn K.M., Rhee M.H., Peng N., Oliveira-dos-Santos A., Penninger J.M., Muslin A.J., Steinberg T.H., et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J. Clin. Invest. 111 (2003) 445-452
70. Rogers J.H., Tamirisa P., Kovacs A., Weinheimer C., Courtois M., Blumer K.J., Kelly D.P., and Muslin A.J. RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. J. Clin. Invest. 104 (1999) 567-576
71. Chowdari K.V., Mirnics K., Semwal P., Wood J., Lawrence E., Bhatia T., Deshpande S.N., T B.K., Ferrell R.E., Middleton F.A., et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum. Mol. Genet. 11 (2002) 1373-1380
72. Morris D.W., Rodgers A., McGhee K.A., Schwaiger S., Scully P., Quinn J., Meagher D., Waddington J.L., Gill M., and Corvin A.P. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 125B (2004) 50-53
73. Chen X., Dunham C., Kendler S., Wang X., O'Neill F.A., Walsh D., and Kendler K.S. Regulator of G-protein signaling 4 (RGS4) gene is associated with schizophrenia in Irish high density families. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 129B (2004) 23-26
74. Tamirisa P., Blumer K.J., and Muslin A.J. RGS4 inhibits G-protein signaling in cardiomyocytes. Circulation 99 (1999) 441-447
75. Rogers J.H., Tsirka A., Kovacs A., Blumer K.J., Dorn II G.W., and Muslin A.J. RGS4 reduces contractile dysfunction and hypertrophic gene induction in Galpha q overexpressing mice. J. Mol. Cell. Cardiol. 33 (2001) 209-218
76. Heximer S.P., Srinivasa S.P., Bernstein L.S., Bernard J.L., Linder M.E., Hepler J.R., and Blumer K.J. G protein selectivity is a determinant of RGS2 function. J. Biol. Chem. 274 (1999) 34253-34259
77. Traynor J.R., and Neubig R.R. Regulators of G protein signaling & drugs of abuse. Mol. Interv. 5 (2005) 30-41
78. Cladman W., and Chidiac P. Characterization and comparison of RGS2 and RGS4 as GTPase-activating proteins for m2 muscarinic receptor-stimulated G(i). Mol. Pharmacol. 62 (2002) 654-659
79. Tang K.M., Wang G.R., Lu P., Karas R.H., Aronovitz M., Heximer S.P., Kaltenbronn K.M., Blumer K.J., Siderovski D.P., Zhu Y., et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat. Med. 9 (2003) 1506-1512
80. Grant S.L., Lassegue B., Griendling K.K., Ushio-Fukai M., Lyons P.R., and Alexander R.W. Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol. Pharmacol. 57 (2000) 460-467
81. Hao J., Michalek C., Zhang W., Zhu M., Xu X., and Mende U. Regulation of cardiomyocyte signaling by RGS proteins: differential selectivity towards G proteins and susceptibility to regulation. J. Mol. Cell. Cardiol. 41 (2006) 51-61
82. Zhang W., Anger T., Su J., Hao J., Xu X., Zhu M., Gach A., Cui L., Liao R., and Mende U. Selective loss of fine tuning of Gq/11 signaling by RGS2 protein exacerbates cardiomyocyte hypertrophy. J. Biol. Chem. 281 (2006) 5811-5820
83. Levay K., Cabrera J.L., Satpaev D.K., and Slepak V.Z. Gbeta5 prevents the RGS7-Galphao interaction through binding to a distinct Ggamma-like domain found in RGS7 and other RGS proteins. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2503-2507
84. Makino E.R., Handy J.W., Li T., and Arshavsky V.Y. The GTPase activating factor for transducin in rod photoreceptors is the complex between RGS9 and type 5 G protein beta subunit. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 1947-1952
85. Snow B.E., Krumins A.M., Brothers G.M., Lee S.F., Wall M.A., Chung S., Mangion J., Arya S., Gilman A.G., and Siderovski D.P. A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13307-13312
86. Jones P.G., Lombardi S.J., and Cockett M.I. Cloning and tissue distribution of the human G protein beta 5 cDNA. Biochim. Biophys. Acta 1402 (1998) 288-291
87. Ford C.E., Skiba N.P., Bae H., Daaka Y., Reuveny E., Shekter L.R., Rosal R., Weng G., Yang C.S., Iyengar R., et al. Molecular basis for interactions of G protein betagamma subunits with effectors. Science 280 (1998) 1271-1274
88. Bonacci T.M., Mathews J.L., Yuan C., Lehmann D.M., Malik S., Wu D., Font J.L., Bidlack J.M., and Smrcka A.V. Differential targeting of Gbetagamma-subunit signaling with small molecules. Science 312 (2006) 443-446
89. E. Toyota, W. Chilian, D. Warltier, T. Brock, E. Ritman, VEGF is crucial for coronary collateral growth in the rat, American Heart Scientific Sessions Circulation-Supple II, 2002 (Abstract #573).
90. Yuan C., Sato M., Lanier S.M., and Smrcka A.V. Signaling by a non-dissociated complex of G Protein betagamma and alpha subunits stimulated by a receptor-independent activator of G protein signaling, AGS8. J. Biol. Chem. 282 (2007) 19938-19947
91. Wall M.A., Coleman D.E., Lee E., Iniguez-Lluhi J.A., Posner B.A., Gilman A.G., and Sprang S.R. The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell 83 (1995) 1047-1058
92. Dell E.J., Connor J., Chen S., Stebbins E.G., Skiba N.P., Mochly-Rosen D., and Hamm H.E. The betagamma subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins. J. Biol. Chem. 277 (2002) 49888-49895
93. Chen S., Spiegelberg B.D., Lin F., Dell E.J., and Hamm H.E. Interaction of Gbetagamma with RACK1 and other WD40 repeat proteins. J. Mol. Cell. Cardiol. 37 (2004) 399-406
94. Chen S., Dell E.J., Lin F., Sai J., and Hamm H.E. RACK1 regulates specific functions of Gbetagamma. J. Biol. Chem. 279 (2004) 17861-17868
95. Korzick D.H., Holiman D.A., Boluyt M.O., Laughlin M.H., and Lakatta E.G. Diminished alpha1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am. J. Physiol. Heart Circ. Physiol. 281 (2001) H581-589
96. O'Donovan H.C., Kiely P.A., and O'Connor R. Effects of RACK1 on cell migration and IGF-I signalling in cardiomyoctes are not dependent on an association with the IGF-IR. Cell Signal. 19 (2007) 2588-2595
97. Jarvis S.E., Magga J.M., Beedle A.M., Braun J.E., and Zamponi G.W. G protein modulation of N-type calcium channels is facilitated by physical interactions between syntaxin 1A and Gbetagamma. J. Biol. Chem. 275 (2000) 6388-6394
98. Jarvis S.E., Barr W., Feng Z.P., Hamid J., and Zamponi G.W. Molecular determinants of syntaxin 1 modulation of N-type calcium channels. J. Biol. Chem. 277 (2002) 44399-44407
99. Kang Y., Ng B., Leung Y.M., He Y., Xie H., Lodwick D., Norman R.I., Tinker A., Tsushima R.G., and Gaisano H.Y. Syntaxin-1A actions on sulfonylurea receptor 2A can block acidic pH-induced cardiac K(ATP) channel activation. J. Biol. Chem. 281 (2006) 19019-19028
100. 2+-dependent binding of synaptotagmin to the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Mol. Pharmacol. 72 (2007) 1210-1219
101. Peters C.G., Miller D.F., and Giovannucci D.R. Identification, localization and interaction of SNARE proteins in atrial cardiac myocytes. J. Mol. Cell. Cardiol. 40 (2006) 361-374
102. Lee R.H., Lieberman B.S., and Lolley R.N. A novel complex from bovine visual cells of a 33,000-dalton phosphoprotein with beta- and gamma-transducin: purification and subunit structure. Biochemistry 26 (1987) 3983-3990
103. Danner S., and Lohse M.J. Phosducin is a ubiquitous G-protein regulator. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 10145-10150
104. Klenk C., Humrich J., Quitterer U., and Lohse M.J. SUMO-1 controls the protein stability and the biological function of phosducin. J. Biol. Chem. 281 (2006) 8357-8364
105. Thibault C., Feng Wang J., Charnas R., Mirel D., Barhite S., and Miles M.F. Cloning and characterization of the rat and human phosducin-like protein genes: structure, expression and chromosomal localization. Biochim. Biophys. Acta 1444 (1999) 346-354
106. Schroder S., and Lohse M.J. Quantification of the tissue levels and function of the G-protein regulator phosducin-like protein (PhlP). Naunyn Schmiedebergs Arch. Pharmacol. 362 (2000) 435-439
107. Thibault C., Sganga M.W., and Miles M.F. Interaction of phosducin-like protein with G protein betagamma subunits. J. Biol. Chem. 272 (1997) 12253-12256
108. Gaudet R., Bohm A., and Sigler P.B. Crystal structure at 2.4 angstroms resolution of the complex of transducin betagamma and its regulator, phosducin. Cell 87 (1996) 577-588
109. Schroder S., and Lohse M.J. Inhibition of G-protein betagamma-subunit functions by phosducin-like protein. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 2100-2104
110. Li Z., Laugwitz K.L., Pinkernell K., Pragst I., Baumgartner C., Hoffmann E., Rosport K., Münch G., Moretti A., Humrich J., Lohse M.J., and Ungerer M. Effects of two Gbetagamma-binding proteins - N-terminally truncated phosducin and beta-adrenergic receptor kinase C terminus (betaARKct) - in heart failure. Gene Ther. 10 (2003) 1354-1361
111. Li S., Okamoto T., Chun M., Sargiacomo M., Casanova J.E., Hansen S.H., Nishimoto I., and Lisanti M.P. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem. 270 (1995) 15693-15701
112. Oh P., and Schnitzer J.E. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 12 (2001) 685-698
113. Elliott M.H., Fliesler S.J., and Ghalayini A.J. Cholesterol-dependent association of caveolin-1 with the transducin alpha subunit in bovine photoreceptor rod outer segments: disruption by cyclodextrin and guanosine 5′-O-(3-thiotriphosphate). Biochemistry 42 (2003) 7892-7903
114. Patel H.H., Murray F., and Insel P.A. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 48 (2008) 359-391
115. Han Y., Chen Y.S., Liu Z., Bodyak N., Rigor D., Bisping E., Pu W.T., and Kang P.M. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ. Res. 99 (2006) 415-423
116. Pitcher J.A., Inglese J., Higgins J.B., Arriza J.L., Casey P.J., Kim C., Benovic J.L., Kwatra M.M., Caron M.G., and Lefkowitz R.J. Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors. Science 257 (1992) 1264-1267
117. Daaka Y., Pitcher J.A., Richardson M., Stoffel R.H., Robishaw J.D., and Lefkowitz R.J. Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2180-2185
118. Vaiskunaite R., Kozasa T., and Voyno-Yasenetskaya T.A. Interaction between the G alpha subunit of heterotrimeric G(12) protein and Hsp90 is required for G alpha(12) signaling. J. Biol. Chem. 276 (2001) 46088-46093